International Drug Development Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:International Drug Development Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9328
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical services comprise study design, clinical development strategy, biostatistical analysis, interim analysis, biomarker validation and medical writing, among others. IDDI’s risk-based monitoring services include risk indicator and central statistical monitoring. The institute offers clinical research services in therapeutic areas of cancer research, ophthalmology, rare diseases and biosimilars. It caters to pharmaceutical companies, biotechs, start-ups, academic groups and CROs. IDDI is headquartered in Louvain-la-Neuve, Belgium.

International Drug Development Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Drug Development Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International Drug Development Institute, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
International Drug Development Institute Partners with Ophthotech 10
International Drug Development Institute Partners with Oraya Therapeutics 11
International Drug Development Institute Partners with Exonhit 12
International Drug Development Institute – Key Competitors 13
International Drug Development Institute – Key Employees 14
International Drug Development Institute – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
International Drug Development Institute, Pharmaceuticals & Healthcare, Key Facts 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Drug Development Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Drug Development Institute, Deals By Therapy Area, 2012 to YTD 2018 8
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International Drug Development Institute Partners with Ophthotech 10
International Drug Development Institute Partners with Oraya Therapeutics 11
International Drug Development Institute Partners with Exonhit 12
International Drug Development Institute, Key Competitors 13
International Drug Development Institute, Key Employees 14
International Drug Development Institute, Subsidiaries 15

List of Figures
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[International Drug Development Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • H.I.S. Co Ltd:企業の戦略・SWOT・財務分析
    H.I.S. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • WorleyParsons Ltd (WOR):電力:M&Aディール及び事業提携情報
    Summary WorleyParsons Ltd (WorleyParsons) is a provider of professional services. Its services cover the full lifecycle, from creating new assets to sustaining and enhancing operating assets. The company provides integrated solution for deepwater developments with the associated subsea, pipelines, r …
  • Trane Technologies Plc (TT):企業の財務・戦略的SWOT分析
    Trane Technologies Plc (TT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Aernnova Aerospace, S.A.:企業の戦略・SWOT・財務情報
    Aernnova Aerospace, S.A. - Strategy, SWOT and Corporate Finance Report Summary Aernnova Aerospace, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Intertape Polymer Group Inc (ITP):企業の財務・戦略的SWOT分析
    Intertape Polymer Group Inc (ITP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Guangdong Electric Power Development Co Ltd (000539):電力:M&Aディール及び事業提携情報
    Summary Guangdong Electric Power Development Co., Ltd. (Guangdong Electric) is a leading china based electricity distribution company. The company is a subsidiary of Guangdong Yudean Group Co., Ltd. Guangdong Electric is engaged in developing electric power plants in the country. The company is also …
  • ULURU Inc (ULUR):医療機器:M&Aディール及び事業提携情報
    Summary ULURU Inc (ULURU) is a medical technology company that researches, develops, and markets wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wo …
  • Sunstone Hotel Investors, Inc.:企業のM&A・事業提携・投資動向
    Sunstone Hotel Investors, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sunstone Hotel Investors, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Centogene AG:医療機器:M&Aディール及び事業提携情報
    Summary Centogene AG (Centogene) is a biotechnology and genetic diagnostic company which offers genetic testing for rare hereditary disorders. The company provides diagnostic services including whole genome sequencing, whole exome sequencing, clinical exome sequencing, NGS panel genomic, carrier scr …
  • Shenergy Co., Ltd. (600642):電力:M&Aディール及び事業提携情報
    Summary Shenergy Company, Ltd. (Shenergy) is China-based gas and electricity company. The company is engaged in the construction, investment, operations and management of petroleum, natural gas and electric power. Its electricity projects include hydropower, coal-fired power and thermal power genera …
  • Bayer HealthCare Pharmaceuticals:医療機器:M&Aディール及び事業提携情報
    Summary Bayer HealthCare Pharmaceuticals (Bayer Healthcare), formerly Bayer Schering Pharma AG, a subsidiary of Bayer AG, is the pharmaceutical company that develops, manufactures and markets prescription products in the areas of general medicine and specialty medicine. The company offer prescriptio …
  • San Leon Energy Plc (SLE):企業の財務・戦略的SWOT分析
    Summary San Leon Energy Plc (San Leon) is an oil and gas exploration and production company. It is engaged in acquiring, exploring and developing conventional and shale oil and gas assets across Europe and North Africa. The company holds interests in Durresi Block located in offshore Albania and inc …
  • iPass Inc. (IPAS):企業の財務・戦略的SWOT分析
    iPass Inc. (IPAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tianjin Chase Sun Pharmaceutical Co Ltd (300026):製薬・医療:M&Aディール及び事業提携情報
    Summary Tianjin Chase Sun Pharmaceutical Co Ltd (Chase Sun) is a medicine and health industry group. The company research, develops, produces, and markets various pharmaceutical products. It offers products such as Chinese herb preparations, Chinese medicinal granules, synthetic drugs, biotech drugs …
  • Veeco Instruments Inc (VECO):電力:M&Aディール及び事業提携情報
    Summary Veeco Instruments Inc (Veeco) is a technology company that designs, manufacture and market thin film equipments. The company offers various products and technologies which include MOCVD systems, precision surface processing system, MBE technologies, ion beam sputtering, physical vapor deposi …
  • Tempur Sealy International, Inc. (TPX):企業の財務・戦略的SWOT分析
    Tempur Sealy International, Inc. (TPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Faron Pharmaceuticals Oy (FARN):製薬・医療:M&Aディール及び事業提携情報
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascu …
  • HomeServe plc (HSV):企業の財務・戦略的SWOT分析
    HomeServe plc (HSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • CSS Industries, Inc. (CSS):企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • IXICO Plc (IXI):企業の財務・戦略的SWOT分析
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as Assessa and trial tracker. Assessa provides web-based platform to tra …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆